Wutah pendapatan kuartal marang kuartal: Erasca (ERAS)

Logo grafis erasca.com (ERAS)

Erasca, Inc. (ERAS) brings together leading oncologists to achieve the complete eradication of malignant tumors. The business focuses on developing RAS/MAPK pathway inhibitors for precision therapy, while biomaterial delivery is ensured via strict climate control. The quarterly revenue growth index reflects current sales dynamics, while 0.00 marks a new level, allowing investors to filter out inflationary noise from the company's actual expansion.

ERAS (Erasca Inc) riwayat Wutah dodolan triwulanan saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan Erasca (ERAS)

- rega saham lan target rega konsensus:
- indikator kapitalisasi bursa perusahaan:
Analisis fundamental perusahaan:ERAS - Erasca
Barang unggulan erasca.com

Institutional capital evaluates Erasca, Inc. (ERAS) through the lens of commercial scalability. The quarterly sales dynamics capture the percentage shift in revenue relative to the previous period, revealing hidden liquidity trends. For a biotech company, this indicator serves as a marker for the efficiency of monetizing R&D results in oncology. Steady growth in this metric confirms the resilience of the business model, supported by sufficient capital reserves to navigate clinical phases.

Pesaing langsung

BeiGene Oncology - Wutah pendapatan triwulanan|HALO: Wutah pendapatan kuartal marang kuartal|Revolution Medicines Corp (RVMD) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Ascentage Pharma Group International (AAPG)|Wutah pendapatan kuartal marang kuartal CG Oncology, Inc.|Tingkat wutah pendapatan sajrone kuartal UroGen Pharma Corp URGN|Wutah pendapatan triwulanan BCAX|Personalis, Inc. - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan DCTH (Delcath Systems)|Tambahing pendapatan triwulanan YMAB|AURA - Wutah pendapatan kuartal marang kuartal|candeltx.com - Owah-owahan dodolan kuartal marang kuartal|ARAY: Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal SLS (SELLAS Life Sciences Group, Inc.)|ACTU (Actuate Therapeutics) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan Citius Oncology Inc. (CTOR)|Wutah pendapatan kuartal marang kuartal TuHURA (HURA)|TARA - Tingkat wutah pendapatan sajrone kuartal|Wutah pendapatan triwulanan FATE (Fate Therapeutics Inc)|Aadi Bioscience Inc (WHWK) - Tingkat wutah pendapatan sajrone kuartal|TScan - Wutah pendapatan triwulanan|Champions Oncology, Inc. (CSBR) - Wutah dodolan triwulanan|XBIT (XBiotech Inc.) - Wutah dodolan triwulanan|CEL-SCI Corporation (CVM) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal OS Therapies|RADX: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal artivabio.com (ARTV)|Tingkat wutah dodolan sajrone kuartal Adlai Nortye|Wutah pendapatan triwulanan VERU (Veru Corporation)|Owah-owahan dodolan kuartal marang kuartal TPST (Tempest Tx)|XLO: Wutah dodolan triwulanan|renovarobio.com (RENB) - Wutah dodolan triwulanan|Mural Bio (MURA) - Wutah pendapatan kuartal marang kuartal|Kairos Pharma Inc (KAPA) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan OKUR|CytoMed Therapeutics (GDTC) - Tingkat wutah dodolan sajrone kuartal|Wutah dodolan triwulanan CRIS (Curis Inc.)|Wutah pendapatan triwulanan Apollomics Inc. (APLM)|Wutah pendapatan kuartal marang kuartal Tharimmune Corp THAR|Advanced Biomed Corp - Wutah pendapatan kuartal marang kuartal|GNPX: Wutah dodolan triwulanan|Calidi Biotherapeutics, Inc. (CLDI) - Wutah dodolan triwulanan|SBFM: Wutah pendapatan triwulanan|Wutah dodolan triwulanan Xenetic Biosciences Inc.|Wutah pendapatan kuartal marang kuartal Salarius Pharmaceuticals Inc|PPBT: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan AONC|BGNE (BeOne Medicines) - Tambahing pendapatan triwulanan|Checkpoint Therapeutics, Inc - Wutah dodolan triwulanan|elevationoncology.com (ELEV) - Tingkat wutah pendapatan sajrone kuartal|iCAD Inc. - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Ikena Oncology|NTBL: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Viracta (VIRX)|MOR (MorphoSys AG) - Wutah pendapatan triwulanan|NAYA: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Ascentage Pharma Group Ltd (AAPGV)